AMGN Summary

  1. NASDAQ
  2. >
  3. AMGN
TickerAMGN
DescriptionAMGEN INC
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees24,300
Next Earnings DateFebruary 1st, 2022
Ex-Dividend DateFebruary 14th, 2022
Yield3.39013%
Dividend$1.94
IV29.094495%
IV Percentile98th
IV Rank61.82%
IV Skew5.511066
IV Skew Percentile23rd
IV Skew SentimentBullish
Option Volume8,538
Volume4,419,492
Price$226.10
Previous Close$227.72
52-Week High$276.69
52-Week Low$198.64
50-Day Moving Avg.$223.56
200-Day Moving Avg.$219.07
10-Day Avg. Volume2,852,700
20-Day Avg. Volume2,359,984
30-Day Avg. Volume2,325,662
3-Month Avg. Volume2,803,381
PE23.59794
EPS$9.70
Outstanding Shares563,265,902
Market Capitalization$128,931,565,000
CurrencyUSD
UpdatedJanuary 24th, 2022